✦ LIBER ✦

PDB28 THE COST-EFFECTIVENESS ANALYSIS OF VIDALGLIPTIN IN TYPE 2 DIABETES IN POLAND

✍ Scribed by J Walczak; G Nogas; E Gebus; D Pawlik; K Pacocha

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB27 THE COST-EFFECTIVENESS OF INSULIN

✍ J Walczak; W Dardzinski; M Kusy; J Lis; G Nogas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PDB28 COST-EFFECTIVENESS ANALYSIS OF ACA

✍ K JongMann; JP Clegg; K Chang; P JuYeol; KU Wittrup-Jensen; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PDB18 THE COMPLICATIONS IMPACT ON DIABET

✍ MP Niewada; CA Glogowski; M Latek; A Pietrasik; B Kamiñski; JM Gierczynski; A Kr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

PDB6 PREVENTION OF TYPE 2 DIABETES IN TH

✍ AJ Palmer; S Roze 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAX

✍ de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB9 Cost-Effectiveness Analysis of Saxa

✍ E.E. Arinina; M. Rashyd 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB